Nutrition Therapy in End-Stage Lung Disease
- 162 Downloads
Purpose of Review
This review highlights the importance of nutrition support via counseling and oral nutrition supplements as needed in patients with end-stage lung disease. As chronic obstructive pulmonary disease, cystic fibrosis, pulmonary fibrosis are the most common chronic lung disease, the review will focus on these disease processes specifically. It will also discuss the role of nutrition in lung infections like tuberculosis, and the importance of nutrition in lung transplant.
Recent evidence does indicate that nutritional support is essential in the management of patients with end-stage lung disease.
The benefits of nutrition support are greatest when combined with a pulmonary rehabilitation program. Ongoing research, however, is needed to find a solution to weight loss, in particular, the loss of fat-free body mass, as the ideal nutritional regimen for each disease process remains elusive.
KeywordsCOPD Pulmonary cachexia Pulmonary fibrosis Malnutrition Cystic fibrosis End-stage lung disease Tuberculosis
Compliance with Ethical Standards
Conflict of Interest
Loan Nguyen, Alessandra Morello Gearhart, Rodrigo Cavallazzi, and Karen Allen declare that they have no conflict of interest.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Papers of particular interest, published recently, have been highlighted as: •• Of major importance
- 3.Vandenbergh E, Van de Woestijne KP, Gyselen A. Weight changes in the terminal stages of chronic obstructive pulmonary disease. Relation to respiratory function and prognosis. Amer Rev of Resp Dis. 1967;95(4):556-66.Google Scholar
- 4.•• Collins PF, Stratton Rebecca J, Marinos E. Nutritional support in chronic obstructive pulmonary disease: a systemic review and meta-analysis. Am J Clin Nutr. 2012;95:1385–95. doi: 10.3945/ajcn.111.023499. A good subjective analysis of oral nutrition supplements for patients with COPD. CrossRefPubMedGoogle Scholar
- 5.Donahoe, M. Nutritional support in advanced lung disease. The pulmonary cachexia syndrome. Clin Chest Med. 1997;18(3): 547–61.Google Scholar
- 8.•• Global Initiative for Chronic Obstructive Lung Disease (GOLD Guidelines) 2017. PulmCCM Inc. http://pulmccm.org/main/2016/copd-review/new-2017-gold-guidelines-copd-released/ . An excellent overall review for diagnosis and management of COPD.
- 13.Vestbo J, Prescott E, Almdal T, et al. Body mass, fat-free body mass, and prognosis in patients with chronic obstructive pulmonary disease from a random population sample. Findings from the Copenhagen City Heart Study. Am J Respir Crit Care Med. 2006;173:79–83.Google Scholar
- 14.Ferreria IM, Brooks D, Lancasse Y, Goldstein RS. Nutritional support for individuals with COPD: a meta-analysis. Chest Med. 2000;117:671–8.Google Scholar
- 15.Ferreira I. Update nutritional support for patients with COPD. Respir Med. 2008;4:127–31.Google Scholar
- 16.Ferreira IM, Brooks D, Lacasse Y, Goldstein RS, White J. Nutritional supplementation for stable chronic obstructive pulmonary disease Cochrane Database Syst Rev. 2005;(2):CD000998.pub2.Google Scholar
- 17.Ferreira IM, Brooks D, White J, Goldstein R. Nutritional supplementation for stable chronic obstructive pulmonary disease 12 December 2012. doi: 10.1002/14651858.CD000998.pub3
- 20.Gurgun Alev A. Effects of nutritional supplementation combined with conventional pulmonary rehabilitation in muscle-wasted chronic obstructive pulmonary disease: a prospective, randomized and controlled study. Respirology. 18(3):495–500.Google Scholar
- 25.•• Steiner MC, Barton RL, Singh SJ, M.D.L. Morgan bedside methods versus dual energy X-ray absorptiometry for body composition measurement in COPD. Eur Respir J. 2002;19:626–31. doi: 10.1183/09031936.02.00279602. Good article to evaluate assessment of body composition for patients with chronic lung disease. CrossRefGoogle Scholar
- 27.Hamosh A, et al. Comparison of the clinical manifestations of cystic fibrosis in black and white patients. J Pediatr. 132(2):255–9.Google Scholar
- 28.Cystic Fibrosis Foundation Patient Registry: Annual Data Report to the Center Directors, 2015. https://www.cff.org/Our-Research/CF-Patient-Registry/2015-Patient-Registry-Annual-Data-Report.pdf.
- 34.Thaker V, et al. Recombinant growth hormone therapy for cystic fibrosis in children and young adults. Cochrane Database Syst Rev. 2013;6:CD00891.Google Scholar
- 39.American Thoracic Society/European Respiratory Society international multidisciplinary consensus classification of the idiopathic interstitial pneumonias. 2002. 165(2): p. 277–304.Google Scholar
- 43.Nishiyama O, et al. A simple assessment of dyspnoea as a prognostic indicator in idiopathic pulmonary fibrosis. Eur Respir J. 2010;36(5):1067–72.Google Scholar
- 53.WHO, Guideline. Nutritional care and support for patients with tuberculosis. Geneva: World Health Organization; 2013.Google Scholar
- 54.Sinclair D, et al. Nutritional supplements for people being treated for active tuberculosis. Cochrane Database Syst Rev, 2011(11):Cd006086.Google Scholar
- 56.Adegunsoye A, Strek ME, Garrity E, Guzy R, Bag R. Comprehensive Care of the Lung Transplant Patient. Chest. 2017;152(1):150-164. doi: 10.1016/j.chest.2016.10.001